Filter News
Area of Research
News Topics
- (-) Computer Science (2)
- (-) Isotopes (2)
- (-) Materials Science (1)
- (-) Sustainable Energy (3)
- (-) Transportation (2)
- 3-D Printing/Advanced Manufacturing (3)
- Advanced Reactors (2)
- Bioenergy (1)
- Biomedical (2)
- Decarbonization (1)
- Energy Storage (2)
- Environment (1)
- Fusion (1)
- Neutron Science (2)
- Nuclear Energy (6)
- Physics (1)
- Polymers (1)
- Space Exploration (1)
- Summit (1)
- Transformational Challenge Reactor (1)
Media Contacts
In the quest for advanced vehicles with higher energy efficiency and ultra-low emissions, ORNL researchers are accelerating a research engine that gives scientists and engineers an unprecedented view inside the atomic-level workings of combustion engines in real time.
Oak Ridge National Laboratory researchers have developed a new family of cathodes with the potential to replace the costly cobalt-based cathodes typically found in today’s lithium-ion batteries that power electric vehicles and consumer electronics.
Four research teams from the Department of Energy’s Oak Ridge National Laboratory and their technologies have received 2020 R&D 100 Awards.
The combination of bioenergy with carbon capture and storage could cost-effectively sequester hundreds of millions of metric tons per year of carbon dioxide in the United States, making it a competitive solution for carbon management, according to a new analysis by ORNL scientists.
After its long journey to Mars beginning this summer, NASA’s Perseverance rover will be powered across the planet’s surface in part by plutonium produced at the Department of Energy’s Oak Ridge National Laboratory.
The Department of Energy’s Oak Ridge National Laboratory is collaborating with industry on six new projects focused on advancing commercial nuclear energy technologies that offer potential improvements to current nuclear reactors and move new reactor designs closer to deployment.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.